{"id":13695,"date":"2024-06-17T16:18:02","date_gmt":"2024-06-17T23:18:02","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13695"},"modified":"2024-06-17T16:18:02","modified_gmt":"2024-06-17T23:18:02","slug":"glp-1-drugs-enable-bariatric-surgery-for-high-risk-patients","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/glp-1-drugs-enable-bariatric-surgery-for-high-risk-patients\/","title":{"rendered":"GLP-1 drugs enable bariatric surgery for high-risk patients"},"content":{"rendered":"<section class=\"kc-elm kc-css-490601 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-204583 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-600855 kc_text_block\">\n<p><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">A study presented at the American Society for Metabolic and Bariatric Surgery&#8217;s annual meeting found that GLP-1 agonist medications, such as semaglutide, can help extremely obese patients lose enough weight to meet criteria for bariatric surgery. Dr. Phil Schauer said combining anti-obesity drugs led to the greatest weight loss, making surgery feasible for those previously deemed too high-risk.<\/span><\/span><\/p>\n<p><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">\u00a0Full Story: <a href=\"https:\/\/newsletter.smartbrief.com\/uyd\/editProfile.action;jsessionid=CEE7F7B5A22CE6166D50EE47FE0DA88B.web1.smartbrief.com?t1=80474810&amp;t2=https%3A%2F%2Fwww.healthday.com%2Fhealth-news%2Fweight-loss%2Fglp-1-meds-may-help-extremely-obese-qualify-for-weight-loss-surgery\">HealthDay News<\/a> (6\/14)\u00a0\u00a0<\/span><\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13695","post","type-post","status-publish","format-link","hentry","category-diabetes-related-news","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13695"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13695\/revisions"}],"predecessor-version":[{"id":13696,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13695\/revisions\/13696"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}